Xiaozhou He

1.6k citations
47 papers · 1.2k indexed · h-index 19
Topics
MicroRNA in disease regulation (18 papers)Cancer-related molecular mechanisms research (17 papers)Circular RNAs in diseases (17 papers)
Partner nations
ChinaUnited StatesItaly

In The Last Decade

Xiaozhou He

46 papers receiving 1.2k citations

Peers

Xiaozhou He
Comparison fields: 5 of 92
  • Molecular Biology 773
  • Cancer Research 627
  • Cellular and Molecular Neuroscience 182
  • Physiology 91
  • Pulmonary and Respiratory Medicine 89
Replace Ning Bai with:
Ning Bai China
Hirofumi Miyazaki Japan
Dandan Song China
Hailin Liu China
Hui Dong China
Daniela Pretti da Cunha Tirapelli Brazil
Jonathan D. Verrier United States
Honglu Chao China
Yu‐Yan Hu China
Bing Zhao China
Xiaozhou He relative to Ning Bai China Ning Bai's profile →
Citations per field
00.5×
Ning Bai · 1×
Citations per year

Countries citing papers authored by Xiaozhou He

Since Specialization
Citations

This map shows the geographic impact of Xiaozhou He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaozhou He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaozhou He more than expected).

Fields of papers citing papers by Xiaozhou He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaozhou He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaozhou He. The network helps show where Xiaozhou He may publish in the future.

Co-authorship network of co-authors of Xiaozhou He

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaozhou He. A scholar is included among the top collaborators of Xiaozhou He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaozhou He. Xiaozhou He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 4
2 0
3 15
4 17
5 11
6 29
7 48
8 15
9 9
10 8
11
Capn4 induces human renal cancer cell proliferation by activating NF-κB signaling pathway through FAK phosphorylation.
2
12 24
13 5
14 26
15 1
16 15
17 15
18 84
19 67
20 1

About Xiaozhou He

Xiaozhou He is a scholar working on Cancer Research, Molecular Biology and Endocrine and Autonomic Systems, having authored 47 papers that have together received 1.2k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (18 papers), Cancer-related molecular mechanisms research (17 papers) and Circular RNAs in diseases (17 papers). The work is most often cited by research in Cancer Research (627 citations), Molecular Biology (773 citations) and Cellular and Molecular Neuroscience (182 citations). Xiaozhou He has collaborated with scholars based in China, United States and Italy. Frequent co-authors include Ying Xia, Yilin Yang, Dongman Chao, Lawrence H. Lazarus, Yuan Feng, Renfang Xu, Xianlin Xu, Donglin Sun, Cui Li and Dong Xue. Their work appears in journals such as PLoS ONE, Brain Research and Cellular and Molecular Life Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026